Aer Therapeutics
Operator of a biopharmaceutical company intended to treat lung disease with excess mucus and mucus plugs. The company focuses on treating respiratory diseases with unmet needs, such as chronic obstruc...
Valuation
$58M
Market implied
Share Price
N/A
Total Raised
$48M
Last Round
N/A